ESR1 and breast cancer: For instance, extreme CIN (as measured by CIN70, CGH, and centromeric FISH probes) was found to correlate with improved long-term survival in estrogen receptor (ER)-negative breast cancer, but poorer outcome in ER-positive breast cancer patients [58].